Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Erowid References Database
Garcia-Osta A, Del Rio J, Frechilla D. 
“Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rat frontal cortex but not in the hippocampus”. 
Brain Res Mol Brain Res. 2004 Jul 26;126(2):181-7.
A single administration of either 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') or p-chloroamphetamine (PCA) produced a rapid and marked reduction of serotonin (5-HT) content in rat frontal cortex and hippocampus. In the cortex of MDMA-treated rats, 5-HT levels returned to control values 48 h after drug administration. This recovery was correlated with an induction of CRE-binding activity and an enhanced expression of tryptophan hydroxylase (TPH) mRNA, the rate-limiting enzyme in 5-HT biosynthesis, suggesting that MDMA may up-regulate the TPH gene through a CREB-dependent mechanism. In the cortex of PCA-treated rats, neither a recovery of 5-HT levels nor changes in DNA-binding or TPH mRNA were found at the same time point. In the hippocampus of rats receiving either PCA or MDMA a decrease in TPH mRNA levels was found at all times, along with a reduced CRE-binding at the 8-h time point. The results show region-specific effects of MDMA. In the frontal cortex, the increased TPH expression suggests a compensatory response to MDMA-induced loss of serotonergic function.
Comments and Responses to this Article
Submit Comment
[ Cite HTML ]